Morning Overview on MSN
New CRISPR variant cuts tumor DNA while sparing healthy cells
Most gene-editing tools are blind to context. Point them at a DNA sequence and they cut, whether that sequence sits inside a ...
Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...
A graphic of a purple and magenta Cas9 protein, which is a somewhat round, but uneven, ball, bound to a yellow and orange ...
April 9, 2026 - By Denise Heady - UCLA scientists have developed a simple and cost-effective blood test that, in early ...
A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types ...
MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.
A team of researchers from UCLA has created a new blood test that may change how doctors detect cancer and other diseases.
Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results